
Neogen Corporation NEOG
$ 9.26
-0.32%
Quarterly report 2026-Q1
added 04-09-2026
Neogen Corporation P/CF Ratio 2011-2026 | NEOG
Annual P/CF Ratio Neogen Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.5 | 108 | 110 | 36 | 47.9 | 49 | 65.9 | 86.1 | 57.8 | 100 | 51.6 | 147 | 75.7 | 111 | 49.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 147 | 17.5 | 74.1 |
P/CF Ratio of other stocks in the Diagnostics research industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 203.59 | -0.44 % | $ 22.6 B | ||
|
Celcuity
CELC
|
-35 | $ 88.87 | -4.02 % | $ 4.16 B | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-0.201 | $ 4.25 | -5.56 % | $ 5.65 M | ||
|
Castle Biosciences
CSTL
|
7.33 | $ 21.19 | 0.52 % | $ 614 M | ||
|
Fulgent Genetics
FLGT
|
-5.18 | $ 19.02 | 2.84 % | $ 585 M | ||
|
Aspira Women's Health
AWH
|
-0.0975 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.0826 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
ICON Public Limited Company
ICLR
|
9.76 | $ 147.15 | -3.08 % | $ 11.5 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
-72.7 | $ 130.83 | 0.55 % | $ 16.4 B | ||
|
Illumina
ILMN
|
23.4 | $ 164.1 | 2.54 % | $ 25.4 B | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 23.71 | 4.22 % | $ 1.26 B | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
Interpace Biosciences
IDXG
|
1.26 | $ 1.76 | 1.32 % | $ 7.79 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
0.495 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-23.5 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-0.877 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 101.96 | 1.98 % | $ 6.88 B | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 187.54 | -1.29 % | $ 9.3 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Pacific Biosciences of California
PACB
|
-4.48 | $ 1.4 | 1.82 % | $ 420 M | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 470.7 | 0.84 % | $ 13.6 B | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
29.7 | $ 1 132.35 | -2.63 % | $ 23.3 B | ||
|
NeoGenomics
NEO
|
284 | $ 11.47 | 0.26 % | $ 1.47 B | ||
|
Myriad Genetics
MYGN
|
227 | $ 4.59 | 0.99 % | $ 425 M | ||
|
National Research Corporation
NRC
|
11.9 | $ 21.0 | 6.33 % | $ 470 M | ||
|
Natera
NTRA
|
142 | $ 218.38 | -1.99 % | $ 29.9 B | ||
|
Personalis
PSNL
|
-5.75 | $ 9.74 | -0.1 % | $ 869 M | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 25.77 | -2.77 % | $ 24.4 B | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 7.22 | -2.83 % | $ 301 M | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
44.5 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.03 | -1.02 % | $ 4.66 M | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 268.15 | -1.12 % | $ 22.3 B | ||
|
Twist Bioscience Corporation
TWST
|
-32.8 | $ 68.37 | -2.41 % | $ 4.09 B | ||
|
Thermo Fisher Scientific
TMO
|
25.1 | $ 482.91 | -2.31 % | $ 182 B | ||
|
Trinity Biotech plc
TRIB
|
-46.3 | $ 0.68 | 2.39 % | $ 244 M | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
Invitae Corporation
NVTA
|
-1.04 | - | - | $ 21.2 M |